Colorectal cancer detection in an asymptomatic population: Fecal immunochemical test for hemoglobin vs. Fecal M2-type pyruvate kinase(329 views) Caviglia GP, Cabianca L, Fagoonee S, Gili FM
Department of Medical Sciences, University of Turin, Turin, Italy
Centro di Prevenzione Oncologica (CPO Piemonte), AOU Città della Salute e della Scienza, Turin, Italy
Institute for Biostructures and Bioimages-CNR c/o Molecular Biotechnology Center, University of Turin, Turin, Italy
References: Zubero, M.B., Arana-Arri, E., Pijoan, J.I., Portillo, I., Idigoras, I., Lopez-Urrutia, A., Population-based colorectal cancer screening: Comparison of two fecal occult blood test (2014) Front Pharmacol, 4, p. 175. , http://dx.doi.org/10.3389/fphar.2013.0017
Fraser, C.G., Rubeca, T., Rapi, S., Chen, L.S., Chen, H.H., Faecal haemoglobin concentrations vary with sex and age, but data are not transferable across geography for colorectal cancer screening (2014) Clin Chem Lab Med, 52, pp. 1211-1216. , http://dx.doi.org/10.1515/cclm-2014-0115
Paska, A.V., Hudler, P., Aberrant methylation patterns in cancer: A clinical view (2015) Biochem Med (Zagreb), 25, pp. 161-176. , http://dx.doi.org/10.11613/BM.2015.017
Senore, C., Reggio, D., Musso, A., Bruno, M., De Angelis, C., Giordanino, C., Narrow band imaging vs. High definition colonoscopy for detection of colorectal adenomas in patients with positive faecal occult blood test: A randomized trial (2014) Dig Liver Dis, 46, pp. 803-807. , http://dx.doi.org/10.1016/j.dld.2014.05.007
Von Karsa, L., Patnick, J., Segnan, N., Atkin, W., Halloran, S., Lansdorp-Vogelaar, I., European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full supplement publication (2013) Endoscopy, 45, pp. 51-59
Tonus, C., Sellinger, M., Koss, K., Neupert, G., Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: A meta-analysis (2012) World J Gastroenterol, 18, pp. 4004-4011. , http://dx.doi.org/10.3748/wjg.v18.i30.4004
Mazurek, S., Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells (2011) Int J Biochem Cell Biol, 43, pp. 969-980. , http://dx.doi.org/10.1016/j.biocel.2010.02.005
Hardt, P.D., Toepler, M., Ngoumou, B., Rupp, J., Kloer, H.U., Measurement of fecal pyruvate kinase type M2 (Tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls (2003) Anticancer Res, 23, pp. 851-853
Abdullah, M., Rani, A.A., Simadibrata, M., Fauzi, A., Syam, A.F., The value of fecal tumor M2 pyruavte kinase as diagnostic tool for colorectal cancer screening (2012) Acta Med Indones, 44, pp. 94-99
Leen, R., Seng-Lee, C., Holleran, G., O’Morain, C., McNamara, D., Comparison of faecal M2-PK and FIT in a population based bowel cancer screening cohort (2014) Eur J Gastroenterol Hepatol, 26, pp. 514-518. , http://dx.doi.org/10.1097/MEG.0000000000000025
Fraser, C.G., Halloran, S.P., Allison, J.E., Young, G.P., Making colorectal cancer screening FITTER for purpose with quantitative faecal immunochemical tests for haemoglobin (FIT) (2013) Clin Chim Lab Med, 51, pp. 2056-2067. , http://dx.doi.org/10.1515/cclm-2013-0408
Fraser, C.G., Allison, J.E., Halloran, S.P., Young, G.P., A proposal to standardize reporting units for faecal immunochemical tests for haemoglobin (2012) J Natl Cancer Inst, 104, pp. 810-814. , http://dx.doi.org/10.1093/jnci/djs190
Hamilton, S., Aaltonene, L., (2000) Pathology and Genetics. Tumours of the Digestive System, , World Health Organization classification of tumours 2nd ed Lyon: International Agency for research on Cancer
Segnan, N., Senore, C., Reoni, B., Azzoni, A., Bisanti, L., Cardelli, A., Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening (2007) Gastroenterology, 132, pp. 2304-2312. , http://dx.doi.org/10.1053/j.gastro.2007.03.030
Shastri, Y.M., Naumann, M., Oremek, G.M., Hanisch, E., Rosch, W., Mossner, J., Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal neoplasia (2006) Int J Cancer, 119, pp. 2651-2656. , http://dx.doi.org/10.1002/ijc.22243
Shastri, Y.M., Loitsch, S., Hoepffner, N., Povse, N., Hanisch, E., Rosch, W., Comparison of an established simple officebased immunological FOBT with fecal tumor pyruvate kinase type M2 (M2-PK) for colorectal cancer screening: Prospective multicenter study (2008) Am J Gastroenterol, 103, pp. 1496-1504. , http://dx.doi.org/10.1111/j.1572-0241.2008.01824.x
Parente, F., Marino, B., Ilardo, A., Fracasso, P., Zullo, A., Hassan, C., A combination of faecal tests for the detection of colon cancer: A new strategy for appropriate selection of referrals to colonoscopy? A prospective multicenter Italian study (2012) Eur J Gastroenterol Hepatol, 24, pp. 1145-1152. , http://dx.doi.org/10.1097/MEG.0b013e328355cc79
Kim, Y.C., Kim, J.H., Cheung, D.Y., Kim, T.H., Jun, E.J., Oh, J.W., The usefulness of a novel screening kit for colorectal cancer using the immunochromatographic fecal tumor M2 pyruvate kinase test (2015) Gut Liver, 9, pp. 641-648. , http://dx.doi.org/10.5009/gnl13457
Zorzi, M., De’ Bianchi, P.S., Grazzini, G., Senore, C., Gruppo di lavoro sugli indicatori del GISCoR. Quality indicators for the evaluation of colorectal cancer screening programs (2007) Epidemiol Prev, 31, pp. 6-56
Koss, K., Maxton, D., Jankowski, J.A.Z., Faecal dimeric M2 pyruvate kinase in colorectal cancer and polyps correlates with tumour staging and surgical intervention (2008) Colorectal Dis, 10, pp. 244-248. , http://dx.doi.org/10.1111/j.1463-1318.2007.01334.x
Colorectal cancer detection in an asymptomatic population: Fecal immunochemical test for hemoglobin vs. Fecal M2-type pyruvate kinase
Kim YH, Shin SW, Pellicano R, Fagoonee S, Choi IJ, Kim YI, Park B, Choi JM, Kim SG, Choi J, Park JY, Oh S, Yang HJ, Lim JH, Im JP, Kim JS, Jung HC, Ponzetto A, Figura N, Malfertheiner P, Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH, Bae SE, Choi KD, Choe J, Kim SO, Na HK, Choi JY, Ahn JY, Jung KW, Lee J, Kim DH, Chang HS, Song HJ, Lee GH, Jung HY, Seta T, Takahashi Y, Noguchi Y, Shikata S, Sakai T, Sakai K, Yamashita Y, Nakayama T, Leja M, Park JY, Murillo R, Liepniece-karele I, Isajevs S, Kikuste I, Rudzite D, Krike P, Parshutin S, Polaka I, Kirsners A, Santare D, Folkmanis V, Daugule I, Plummer M, Herrero R, Tsukamoto T, Nakagawa M, Kiriyama Y, Toyoda T, Cao X, Corral JE, Mera R, Dye CW, Morgan DR, Lee YC, Lin JT, Garcia Martin R, Matia Cubillo A, Lee SH, Park JM, Han YM, Ko WJ, Hahm KB, Leontiadis GI, Ford AC, Ichinose M, Sugano K, Jeong M, Park JM, Han YM, Park KY, Lee DH, Yoo JH, Cho JY, Hahm KB, Bang CS, Baik GH, Shin IS, Kim JB, Suk KT, Yoon JH, Kim YS, Kim DJ * Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer(295 views) N Engl J Med (ISSN: 0028-4793, 0028-4793linking, 1533-4406electronic), 2015 Jun; 30642104201566393291: 749-756. Impact Factor:59.558 ViewExport to BibTeXExport to EndNote